Member Info for Gunner68

Steady I do believe in the science and what we have and believe me I have what I think is a good holding and seen over a 6 figure drop from the highs but also a 6 figure gain from my average I’ve been in for 10 yrs again like most LTH on the 10 out of 10 mice announcement i along with others are probably just disappointed we are dropping basically daily now but my biggest disappointment is the missed time scales they keep putting out though I did notice in the presentation they didn’t mention Q1 Q2 it was end of December beginning and mid year so maybe they do have something to pull out the hat again Agile is the one I think they will announce after the results from the tox studies and maybe after these are released either deals for 1801 1802 or the big one a take over
GLA

Who ever said going to the 3s got a good ribbing on here who s to say it won’t happen totally in the mms hands till news drops and all they’re doing is dropping and collecting for a big payday where as most of us just hold and probably gutted we didn’t unload at the 8 9 and 10 point to then buy back in Hindsight just a wonderful thing we all wish we had
GLA
Come on the SAR
Ps I do think the tweet was a reassurance one as no doubt they carnt say owt

Amazes me that the only time they managed a dead line was with the government grant money yet everything else is pushed down the line but news awaiting toxicology results expected before end dec imho I believe Agile news will be released soon after
GLA
Come on the SAR

I’m hoping once the toxicology report is sorted we go Agile route after the presentation and no control is lost for me a logical route to go down
GLA

Tim Mitchell has given a presentation the the Armchair trader yesterday has anyone got a link to the full article sorry in advance of already posted
GLA

End of year I’d go for under 4 but a good spring board to go into 2022 with quite a few RNS s with good news hopefully and entering clinical trials and receiving milestone payments along the way will go for lower as then won’t be disappointed if it does happen with now news before then as just see the mms chipping away as they do
Would love to be proved wrong and as we know an RNS out the blue could totally change all this around
GLA
Come on the SAR

Deft RR for one

James we’ve had more news this year than at any other time in SARS history this isn’t a personal attack on you or anyone else so the company HAS risen on news and good news it is but an investor can only judge on their entry point and what has happened to the price since then
GLA

James to be honest sick of hearing about what we were that’s a totally selfish attitude and without investor money we would be going no where, if it keeps falling the least I’d expect is an RNS saying the company knows of no reason why it’s lost nearly 50 pc from the high of 10 and no I wasn’t caught up in the spike but for investors who have recently brought in no doubt it’s sickening to see it falling on a day by day occurrence especially when other posters including myself are saying how good the company is
GLA
Come on the SAR

Preclinical development candidate SDC-1801 was nominated from a novel series of compounds designed and identified by Sareum following a rigorous selection process. The company is also completing its assessment of further dual TYK2/JAK1 inhibitors for the potential

treatment of certain cancers and/or as a back-up to SDC-1801.
Didn’t see this before maybe it could be for the other tyk2 jak 1 they are assessing but great to see it’s not a one trick pony and maybe leading to multiple on licensing deals for different targets
GLA

Should of held on manipulation at its best and even looking at the sells v buys if it was that bad would of been a massive swing even though not properly reported
GLA
Come on the SAR

Would be interesting to know how many shares the mms have the buys over the last few months have vastly outweighed the sells so what do they do ? Either raise to get people to sell or drop to cause panick selling nothing has changed apart from the timeline and to get share holder value the price has to be above 10p minimum
GLA
Come on the SAR

In addition, Sierra remains required to pay CPF, on a product-by-product and country-by-country basis, tiered high single-digit to low double-digit royalties on the net sales of any product successfully developed.

Sareum continues to be eligible for 27.5% of the economics of the CRT License Agreement, as amended.
Also part of the new agreement so if successful the royalties alone could be huge
290m was just milestone payments which we are eligible for 27.5pc could be an interesting year next year money wise
GLA
Come on the SAR

Looking forward to listening again between 26 and 28 mins about 1802 he sounded like he was going to let the cat out the bag with 1802 but stopped was to do with progress and something different will look again after work
GLA

737 will be the one leading the way for me with payments comming in first half of the year in possibly 3 different combos and again in his words really excited over clinical studies
Covid results were as in his own words very encouraging results including long Covid
Very positive for the future and imho a deal within 6 months
GLA
Come on the SAR

Get it on a question

Worth having a look at their healthcare and life sciences team and especially where they have worked seems a very good move
GLA
Come on the SAR

Is there a date for the AGM ?

Are Sareum still looking to sell 1801 and 1802 for 800m each or has the price gone up ?

Would be interesting to see how many more have been brought than sold just looking at the end of the day I’d say over the last 6 weeks buys have been higher than sells are they getting short on shares ?